Alpha 2.0
Login Register
» Articles » PMID: 11007914

Interrupting the Inhibiton of Normal Hematopoiesis in Myelogenous Leukemia: a Hypothetical Approach to Therapy

Overview
Journal Stem Cells
Publisher Oxford University Press
Specialties Cell Biology
Reproductive Medicine
Date 2000 Sep 29
PMID 11007914
Citations 5
Authors
M A Lichtman
Affiliations
Soon will be listed here.
Citing Articles

CD37 in acute myeloid leukemia: a novel surface target for drug delivery.

Jeremy E, Artiga E, Elgamal S, Cheney C, Eicher D, Zalponik K Blood Adv. 2024; 9(1):1-14.

PMID: 39348689 PMC: 11732606. DOI: 10.1182/bloodadvances.2024013590.

Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia.

Gao A, Gong Y, Zhu C, Yang W, Li Q, Zhao M Haematologica. 2019; 104(10):1950-1961.

PMID: 30792200 PMC: 6886411. DOI: 10.3324/haematol.2018.214593.

Hematopoiesis and microenvironment in hematological malignancies.

Cheng H, Sun G, Cheng T Cell Regen. 2019; 7(1):22-26.

PMID: 30671226 PMC: 6326248. DOI: 10.1016/j.cr.2018.08.002.

Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.

Geyh S, Rodriguez-Paredes M, Jager P, Khandanpour C, Cadeddu R, Gutekunst J Leukemia. 2015; 30(3):683-91.

PMID: 26601782 DOI: 10.1038/leu.2015.325.

Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts.

Krevvata M, Silva B, Manavalan J, Galan-Diez M, Kode A, Matthews B Blood. 2014; 124(18):2834-46.

PMID: 25139351 PMC: 4314530. DOI: 10.1182/blood-2013-07-517219.